FDA approved the first ever peanut allergy treatment in January 2020

Peanut allergies dropped by 43% after doctors reversed avoidance guidance, but questions remain

The study’s data appear to confirm the policy shift. Still, since the study did not include an examination of infant diet, researchers can’t definitively say that the guideline shift led to dietary changes and thus directly caused the decline.

Researchers are investigating if nanoparticle treatments could combat allergies

In rodent work, Northwestern University’s Evan Scott (now at the University of Virginia) and his colleagues have been trying to attack allergies with specially designed nanoparticles—miniscule lab-made objects that can penetrate cells. They stud the nanoparticles with a tiny bit of the allergen specific to the allergy (i.e. cashew protein for cashew allergy) and antibodies that shut down allergic response processes.

Unlike food allergens, encountering inhaled allergens—like pollen—rarely causes life-threatening illness.

Knowing how to use an EpiPen is a life-saving skill—learn how with this video

If someone has a severe allergic response, including trouble breathing or two or more allergic symptoms, it may be necessary to administer epinephrine, usually through an injection. Epinephrine autoinjectors—often called EpiPens—should be injected into the mid-outer thigh, even through clothing, for about 10 seconds, depending on brand. Sometimes another injection with a separate EpiPen is required if the patient does not get better after a few minutes.

Peptides like GLP-1 account for 31 of 370 new drugs approved by the US FDA between 2016 and 2023.

Inhalers, antihistamines, immunotherapy, and more have made allergies a multimillion-dollar market

Market research suggests that the allergies market will continue to grow in the years ahead as the number of allergy diagnoses increases, identifying new patients. Areas of growth include the increasing interest in immunotherapies designed to retrain the immune system through regular exposure to potential allergens via injections and under-the-tongue medical formulations, among other approaches.

One-third of kids with food allergies report being bullied because of it, surprising parents

Research published in 2021 surveyed how more than 100 kids with food allergies were treated by their peers. About one-third of the surveyed kids had their allergies used against them. Bullying tactics included that their allergens were sometimes intentionally put in their food or thrown at them. Parents usually had no idea this bullying was happening.

CRISPR technology is removing allergens from common foods

Proteins responsible for allergies to eggs, milk, wheat, peanuts, and other foods can be genetically edited out of foods to reduce the risk of life-threatening reactions. The technique has also been used to produce caffeine-free coffee beans, spicier tomatoes, allergen-free pets, and more nutritious fish.

More than 90% of America's food allergies are triggered by 9 foods.

Less than 1% of Americans are allergic to penicillin, though about 10% of Americans believe they have this allergy.

Adults are developing food allergies that they didn’t have as children

Research published in 2019 found that almost half of 40,000 surveyed adults with food allergies developed a new food allergy as adults, underscoring that our immune systems may newly misclassify substances later in life.

Gut microbiome rewrites may help reduce allergies

Researchers are investigating different strategies to determine if one day they could give people a combination of gut microbes to set them up for fewer allergies. In animal research, scientists have already prevented severe allergic responses in allergy-prone mice—supplying them with gut microbes from healthy, non-allergic human babies.

US FDA recently approved the first new schizophrenia drug in decades

Though other antipsychotics block dopamine receptors, a new drug, Cobenfy, influences dopamine levels via a different pathway—it stimulates a pair of specialized receptors in the brain that control the release of a substance called acetylcholine. This alternative approach may help patients avoid serious side effects like weight gain. (Some users may experience a paywall.)

The science of food allergies

Why do certain substances trigger an immune response while others don't? Listen to researchers explain the science in this five-minute video. Food allergies affect around 8% of children and 2% of adults in the US, and—unlike sensitivity or intolerance—they involve the immune system mistaking certain harmless proteins in foods as dangerous invaders, triggering a rapid and sometimes severe defense response.

Find dozens of allergen-free recipes

This collection of allergen-free meal and snack recipes, designed by celebrity chefs and others, was curated by the nonprofit Food and Allergy Research & Education group. It includes items like taquitos, pizza, chickpea burgers, various desserts, and more.

Most penicillin allergy diagnoses are wrong, leading to costlier, less effective treatments and contributing to the growing problem of antibiotic resistance.

Unlike milder fears, phobias may get in the way of proceeding with your life.

GLP-1s are netting interest for treating autoimmune diseases, but are considered experimental

Already used to treat type 2 diabetes, the novel medications are showing some early promise in experimental studies at reducing inflammation and treating autoimmune conditions including rheumatoid arthritis and inflammatory bowel conditions. But researchers caution that side effects are still under investigation—rarely the medication has caused lupus, an autoimmune disease.

Diabetes drug GLP-1 is a peptide (that's what the 'P' is for).

In 2015, the FDA approved the first 3D-printed prescription tablet

Spritam, an epilepsy medication, had been too large and difficult to swallow, particularly due to its inability to dissolve easily. The new pill was designed with porous layers to enhance its dissolvability, paving the way for future 3D printing of drugs.

Allergy tests identify antibodies, but not whether allergy symptoms may appear

Skin prick tests and blood tests, the two most common allergy tests, both detect the presence of allergen-specific antibodies. But just because the body has those antibodies doesn’t mean that a person is “allergic” to a substance or that they will develop symptoms of an allergy when encountering the substance. Allergists work with families to interpret the results and sometimes combine that data with approaches including exposure challenges—giving someone a tiny bit of the food or substance they may be allergic to—under medical supervision.

Food allergies were first documented more than 4,000 years ago.

GLP-1 drugs mimic a natural hormone that triggers appetite-suppressing effects

Ozempic, one of the brand names for the drug semaglutide, was originally developed in 2012, to help treat Type 2 diabetes. Among other effects, the drug mimics a naturally produced hormone known as GLP-1, which is released while eating to let our bodies know we are full.

A new daily MS pill is seeking regulatory approval in 2026

In clinical trials, Roche's fenebrutinib showed promise treating primary progressive MS and doubling relapse-free time in patients with relapsing MS as compared to existing treatment. But some liver damage and two possible drug-related deaths in the trials may make it difficult for the drug to net approval. (Some users may encounter a paywall.)

The popularity of new weight loss drugs has led to a diabetes treatment shortage

The FDA approved Ozempic to help patients with diabetes, but the popularity of semaglutide as a weight loss drug led doctors to prescribe Ozempic to nondiabetic patients who needed to lose weight. Ozempic became so popular that manufacturers could not keep pace with demand, posing risks for Ozempic-users with diabetes.

The word allergy is partly derived from the Greek word 'allos' for 'other'

For people with allergies, their immune systems recognize substances as a harmful "other"—cuing an inflammatory response. This podcast explores allergy details and related topics, including how scientists are interested in if the same allergic response mechanisms could underpin other health issues, including severe, painful symptoms around the time of menstrual cycles. Since estrogen acts on white blood cells called mast cells, which leads to the release of histamines—similar to what happens during allergic responses—an understudied question is whether the same process is fueling some of the uncomfortable symptoms around menstruation. An allergist guest notes this raises questions about if antihistamine medications like Pepsid might alleviate them, something that hasn't yet been explored in clinical trials.

The US FDA defines peptides as being 40 amino acids or less.

In 2023, the FDA approved gene therapy for sickle cell disease, enabling one-time infusion bespoke treatments that use a patient's own stem cells to effectively cure a painful condition that disproportionately affects people of African American descent.

Leonard Thompson was the first human to receive an insulin injection for diabetes

In January 1922, the 14-year-old was the first person to receive an insulin injection to treat diabetes, just months after insulin was isolated in dogs and used to treat their induced diabetes. Thompson had an allergic response to an apparent impurity in the injection, but his second dose, 12 days later, was a success.

In June 2026, EU food safety regulators approved sales of a GLP-1-inducing food additive, a change that may lead to 'supercharged' cereals and breads in Europe within a year. (free w/email)

The US FDA issued a 2025 warning about BPC-157 and other popular peptides that are marketed for various regenerative properties.

Bupropion is the only antidepressant approved for the preventive treatment of SAD

Clinical trials showed a 44% reduction in risk for recurrence of SAD for those who took the drug compared to a placebo group. Bupropion is a norepinephrine–dopamine reuptake inhibitor, which increases dopamine (other common antidepressants, known as selective serotonin reuptake inhibitors, sometimes can suppress dopamine, but not always).

See the first dog ever treated with insulin—a peptide

Frederick Banting and his graduate student Charles Best were the first to isolate the peptide insulin from dogs. They induced diabetes in the animals and then treated them with this peptide.

An intense fear must persist for at least six months to be diagnosed as a phobia.

The FDA rejected MDMA-assisted therapy for PTSD in 2024, calling for more research

The decision was considered to be a major setback for moving psychedelics into the mainstream for mental health treatment. Pharmaceutical company Lykos, who had applied for the approval, had already attracted significant support from patients, politicians on both sides of the aisle, and leaders in the mental health field.

In 2026, the FDA proposed a novel approach to expedite reviews of gene therapies for patients with rare genetic disorders such as cystic fibrosis, potentially bypassing the need for years-long clinical trials if approved.

See this list of FDA-approved gene therapies, including offerings for inherited conditions as well as some forms of cancer.

Early peptide research focused on isolating the substances from animal tissue

In the first half of the 20th century, peptides including insulin and adrenocorticotropic hormone were isolated from animals to provide life-saving medicines. ACTH was isolated from the pituitary glands of cows and pigs and insulin was isolated from the pancreas of dogs and cows.

Tirzepatide: A GLP-1 drug that also acts on separate receptors to promote weight loss

Tirzepatide, like semaglutide, is a GLP-1 drug used in diabetes treatment and for weight loss. Unlike semaglutide, it also acts on glucose-dependent insulinotropic polypeptide receptors, proving a second route to reducing appetite as a means to treat diabetes and promote weight loss.

A 1974 Science News article proclaimed that within a decade, light therapy would be on par with traditional drugs.

In 2026, the US FDA approved a light-activated gel combined with red light therapy as a nonsurgical treatment option for the most common type of skin cancer.

Needle-free polio vaccines were offered in Afghanistan for the first time in 2026

Fear of needles has been one barrier to eradicating polio in Afghanistan. Vaccinators are now using a needle-free jet injector to deliver the vaccine through the skin—an approach that's previously been used in other locations. The inoculation includes the inactivated virus vaccine (the vaccine without any live virus in it).

Amish kids have far fewer allergies than the general population

Only about 7% of Amish children in a northern Indiana community have tested positive for common allergens in routine skin prick tests, whereas half of the general US population tests positive for them. Asthma is also extremely uncommon among the Amish, even when compared with other farming communities. Researchers are interested in exploring if approaches like exposing kids across the general population to Amish farm dust might stave off some allergies.

Used since the 1940s, 'forever chemicals' include thousands of different types of substances routinely integrated into industry and consumer products, yet research suggests they can accumulate in the body over time.

The first CRISPR-approved treatment was for sickle cell anemia in 2023

Victoria Gray was the first patient to receive a CRISPR-based therapy, which eliminated her symptoms and restored her health. The therapy's initial cost of $2.2M has kept it out of reach of many patients.

Australian psychiatrists already prescribe psilocybin and MDMA for depression and PTSD

The country green lighted the treatments for July 1, 2023, onward, with MDMA—ectasy—as a post-traumatic stress disorder treatment, and psilocybin—magic mushrooms—as an option for people with treatment-resistant depression.

Medicare in early 2026 did not pay for GLP-1 for obesity treatment, and coverage under Medicaid varied widely by state.

Modern conveniences may be contributing to allergy increases

A combination of genetics and how the environment changes our genes are likely contributing to the rise in allergies. But daily conveniences, such as dishwashers and packaged baby food, also change the level of bacterial exposures in early life, with potential implications for allergy development, experts from Mount Sinai Health System state in this video discussion.

Insurance coverage for GLP-1s remains uneven, but Medicare began covering it in some instances in July 2026.

Seasonal allergies don't always show up in childhood

The human immune system may become sensitized to pollen and develop an allergic reaction to it after prolonged exposure. Other triggers for new seasonal allergies may include exposure to new environments and changing climate conditions that affect allergy season length and conditions for various pollens.